LORTAB Side Effects

7018268-4 | Constipation, Fatigue, Lymph Node Palpable, Metastases To Lung, Platelet Count Increased, Proteinuria, Renal Cancer Metastatic, Vomiting
on Sep 13, 2010 Female patient from UNITED STATES , 71 years of age, weighting 136.7 lb, was diagnosed with renal cell carcinoma and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), fatigue, lymph node palpable, metastases to lung, platelet count increased, proteinuria, renal cancer metastatic, vomiting. Lortab dosage: . During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6964799-2 | Aortic Stenosis, Aortic Valve Sclerosis, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Bradycardia, Chondrocalcinosis, Haemoglobin Decreased, Left Atrial Dilatation, Left Ventricular Dysfunction
Patient was taking Lortab (View Usage). Patient had the following side effects: aortic stenosis, aortic valve sclerosis, aspartate aminotransferase increased, blood alkaline phosphatase increased, bradycardia, chondrocalcinosis, haemoglobin decreased, left atrial dilatation, left ventricular dysfunction on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with arthralgia, osteoarthritis (What is osteoarthritis?) and. Lortab dosage: (1 Tab Prn Oral). During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TYLENOL (View Tylenol Review and Tylenol Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), METFORMIN (View Metformin Review and Metformin Label ), MACROBID (View Macrobid Review and Macrobid Label ). Patient was hospitalized.

6929664-5 | Syncope, Vomiting
Adverse event was reported on Aug 06, 2010 by a Female patient taking Lortab (View Usage) (Dosage: (1 Tab Prn Oral)) was diagnosed with arthralgia, osteoarthritis (What is osteoarthritis?) and. Location: UNITED STATES , 74 years of age, weighting 189.6 lb, After Lortab was administered, patient had the following side effects: syncope, vomiting. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), METFORMIN (View Metformin Review and Metformin Label ), MACROBID (View Macrobid Review and Macrobid Label ). Patient was hospitalized.

6814590-2 | Brain Injury, Cardio-respiratory Arrest, Cardiovascular Disorder, Dependence, Depressed Level Of Consciousness, Lethargy
on Jun 21, 2010 Male patient from UNITED STATES , 46 years of age, was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: brain injury, cardio-respiratory arrest, cardiovascular disorder, dependence, depressed level of consciousness, lethargy. Lortab dosage: . During the same period patient was treated with ACTIQ ((400mcg)) (View Actiq Review and Actiq Label ), PERCOCET (View Percocet Review and Percocet Label ), METHADOSE (View Methadose Review and Methadose Label ), SOMA (View Soma Review and Soma Label ), VALIUM (View Valium Review and Valium Label ), MEPROBAMATE (View Meprobamate Review and Meprobamate Label ).


6763766-1 | Ammonia Increased, Anaemia, Back Pain, Constipation, Depression, Discomfort, Hepatic Cirrhosis, Joint Swelling, Knee Operation
on May 24, 2010 Male patient from UNITED STATES , 49 years of age, weighting 170.0 lb, was diagnosed with back pain (What is back pain?), hepatitis c (What is hepatitis c?) and was treated with Lortab (View Usage). Patient had the following side effects: ammonia increased, anaemia, back pain (What is back pain?), constipation (What is constipation?), depression (What is depression?), discomfort, hepatic cirrhosis, joint swelling, knee operation. Lortab dosage: . During the same period patient was treated with PEG INTRON (View Peg-intron Review and Peg-intron Label ), PEG INTRON (View Peg-intron Review and Peg-intron Label ), REBETOL (View Rebetol Review and Rebetol Label ).

6632695-6 | Depressed Level Of Consciousness, Hypophagia, Ketoacidosis, Metabolic Acidosis, Nausea, Renal Failure Acute, Respiratory Acidosis, Starvation
Patient was taking Lortab (View Usage). After Lortab was administered, patient had the following side effects: depressed level of consciousness, hypophagia, ketoacidosis, metabolic acidosis, nausea (What is nausea?), renal failure acute, respiratory acidosis, starvation on Feb 24, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with psychogenic pain disorder and. Lortab dosage: .

6601925-9 | Cardiac Arrest
Adverse event was reported on Feb 09, 2010 by a Male patient taking Lortab (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), METHADONE HYDROCHLORIDE (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), VICODIN (View Vicodin Review and Vicodin Label ), PAXIL (View Paxil Review and Paxil Label ).

6596769-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Blood Bilirubin Increased, Cardiac Failure Congestive, Condition Aggravated, Crohn's Disease, Gallbladder Disorder
on Feb 01, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with pain (What is pain?) and was treated with Lortab (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), blood bilirubin increased, cardiac failure congestive, condition aggravated, crohn's disease (What is crohn's disease?), gallbladder disorder. Lortab dosage: Pain. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6596641-6 | Product Label Issue, Product Odour Abnormal, Vomiting Projectile
on Feb 22, 2010 Female patient from UNITED STATES , child 9 years of age, weighting 100.0 lb, was diagnosed with foot fracture, pain (What is pain?) and was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: product label issue, product odour abnormal, vomiting projectile. Lortab dosage: 5 5-6 Hrs Po.

6405896-X | Blood Pressure Decreased, Overdose, Renal Failure
Patient was taking Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, overdose, renal failure on Oct 16, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 225.0 lb, was diagnosed with pain (What is pain?) and. Lortab dosage: Zolpidem -ambien- 1 Or 2 At Bedtime. During the same period patient was treated with SOMA (View Soma Review and Soma Label ). Patient was hospitalized and became disabled.

6326223-2 | Arteriosclerosis, Hepatic Congestion, Lividity, Multi-organ Disorder, Muscle Rigidity, Pancreatic Haemorrhage, Pulmonary Congestion, Spleen Congestion
Adverse event was reported on Aug 07, 2009 by a Male patient taking Lortab (View Usage) (Dosage: Po) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 24 years of age, weighting 170.9 lb, Patient had the following side effects: arteriosclerosis, hepatic congestion, lividity, multi-organ disorder, muscle rigidity, pancreatic haemorrhage, pulmonary congestion, spleen congestion. During the same period patient was treated with OPANA ER (10 Mg 2/d Po) (View Opana Er Review and Opana Er Label ), RESTORIL (15 Mg) (View Restoril Review and Restoril Label ), VALIUM (10 Mg) (View Valium Review and Valium Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6299647-X | Hyperhidrosis, Pruritus
on Aug 05, 2009 Male patient from UNITED STATES , 48 years of age, weighting 213.8 lb, was diagnosed with pain in extremity and was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: hyperhidrosis, pruritus. Lortab dosage: 1-2 Tablets Every 6 Hours Prn Po. Patient was hospitalized.

6289596-5 | Inadequate Analgesia, Product Substitution Issue
on Jul 28, 2009 Female patient from UNITED STATES , weighting 207.0 lb, was diagnosed with pain (What is pain?) and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: inadequate analgesia, product substitution issue. Lortab dosage: 7.5 Q4-6 Po }20 Years Ago.

6266537-8 | Hallucination
Patient was taking Lortab (View Usage). Patient had the following side effects: hallucination on Jun 30, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 126.1 lb, . Lortab dosage: Prn. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FLUOROURACIL (400 Mg/m?, Iv Bolus D1+d2 Followed By 5-fu 2400 Mg/m? Over 46-hour Continuous Infusion.) (View Fluorouracil Review and Fluorouracil Label ), ATIVAN (Prn) (View Ativan Review and Ativan Label ), DETROL LA (View Detrol La Review and Detrol La Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6252432-7 |
Adverse event was reported on Jun 15, 2009 by a Male patient taking Lortab (View Usage) (Dosage: Po) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 24 years of age, . During the same period patient was treated with OPANA ER (10 Mg 2/d Po) (View Opana Er Review and Opana Er Label ), RESTORIL (15 Mg) (View Restoril Review and Restoril Label ), VALIUM (10 Mg) (View Valium Review and Valium Label ).

6184176-4 | Chest Pain, Headache, Hepatic Enzyme Increased, Pyrexia, Rash Maculo-papular, Viral Infection
on Apr 20, 2009 Female patient from UNITED STATES , 43 years of age, weighting 184.3 lb, was diagnosed with headache (What is headache?) and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), headache (What is headache?), hepatic enzyme increased, pyrexia, rash maculo-papular, viral infection (What is viral infection?). Lortab dosage: . During the same period patient was treated with CHANTIX (1 Mg 10/d Po) (View Chantix Review and Chantix Label ), DARVOCET (View Darvocet Review and Darvocet Label ). Patient was hospitalized.

6170866-6 | Alcohol Use, Asthenia, Crying, Depression, Family Stress, Fluid Intake Reduced, Hypophagia, Insomnia, Pneumonia
on Apr 10, 2009 Female patient from UNITED STATES , 39 years of age, weighting 175.3 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Lortab (View Usage). Patient had the following side effects: alcohol use, asthenia, crying, depression (What is depression?), family stress, fluid intake reduced, hypophagia, insomnia, pneumonia (What is pneumonia?). Lortab dosage: . During the same period patient was treated with VALIUM (View Valium Review and Valium Label ), PEG INTRON (View Peg-intron Review and Peg-intron Label ), REBETOL (View Rebetol Review and Rebetol Label ). Patient was hospitalized.

6159338-2 | Pain, Product Quality Issue
Patient was taking Lortab (View Usage). After Lortab was administered, patient had the following side effects: pain (What is pain?), product quality issue on Apr 15, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 250.0 lb, . Lortab dosage: .

6140635-1 | Constipation, Crying, Dyspnoea, Hypertension, Impaired Work Ability, Incorrect Dose Administered, Insomnia
Adverse event was reported on Mar 31, 2009 by a Female patient taking Lortab (View Usage) (Dosage: 1 4-6 Hours) was diagnosed with endodontic procedure and. Location: UNITED STATES , 36 years of age, weighting 159.0 lb, Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), crying, dyspnoea, hypertension, impaired work ability, incorrect dose administered, insomnia.

6139716-8 | Confusional State, Nausea
on Dec 24, 2008 Female patient from UNITED STATES , 61 years of age, weighting 261.5 lb, was diagnosed with renal cancer and was treated with Lortab (View Usage). Patient had the following side effects: confusional state, nausea (What is nausea?). Lortab dosage: 7.5 Mg /d Po. During the same period patient was treated with SU 011,428 (50 Mg /d Po) (View Su-011,428 Review and Su-011,428 Label ), DARVOCET (2 Df Prn Po) (View Darvocet Review and Darvocet Label ), OXYCODONE HCL (5 Mg 4/d Po) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ACTOS (View Actos Review and Actos Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6139716-8 | Confusional State, Nausea
on Dec 24, 2008 Female patient from UNITED STATES , 61 years of age, weighting 261.5 lb, was diagnosed with renal cancer and was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: confusional state, nausea (What is nausea?). Lortab dosage: 7.5 Mg /d Po. During the same period patient was treated with SU 011,428 (50 Mg /d Po) (View Su-011,428 Review and Su-011,428 Label ), DARVOCET (2 Df Prn Po) (View Darvocet Review and Darvocet Label ), OXYCODONE HCL (5 Mg 4/d Po) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ACTOS (View Actos Review and Actos Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6133230-1 | Nightmare, Screaming
Patient was taking Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: nightmare, screaming on Mar 24, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 107.0 lb, was diagnosed with endoscopy (What is endoscopy?), septoplasty and. Lortab dosage: I Took 1 Tablet At Night. During the same period patient was treated with HYDROCODONE BITARTRATE + ACETAMINOPHEN (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ).

6100399-4 | Angioedema
Adverse event was reported on Feb 10, 2009 by a Male patient taking Lortab (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, Patient had the following side effects: angioedema.

6076349-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Pain In Extremity, Rhabdomyolysis, Urine Output Decreased
on Jan 23, 2009 Male patient from UNITED STATES , 18 years of age, was diagnosed with pain (What is pain?), weight control (What is weight control?) and was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, pain in extremity, rhabdomyolysis, urine output decreased. Lortab dosage: Po. During the same period patient was treated with HYDROXYCUT (4 Df Po) (View Hydroxycut Review and Hydroxycut Label ), NAPROXEN SODIUM (View Naproxen Sodium Review and Naproxen Sodium Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), ADDERALL 10 (View Adderall 10 Review and Adderall 10 Label ). Patient was hospitalized.

6050680-2 | Arthralgia, Back Pain, Blood Cholesterol Abnormal, Nephrolithiasis, Pain In Extremity
on Jan 21, 2009 Male patient from UNITED STATES , 60 years of age, weighting 190.0 lb, was diagnosed with blood cholesterol increased, neck pain and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), blood cholesterol abnormal, nephrolithiasis, pain in extremity. Lortab dosage: .

6016339-2 | Solitary Kidney
Patient was taking Lortab (View Usage). Patient had the following side effects: solitary kidney on Dec 02, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 8.82 lb, . Lortab dosage: Trp. During the same period patient was treated with REBIF (44 Mcg 3/w, Trp) (View Rebif Review and Rebif Label ), ZOLOFT (Trp) (View Zoloft Review and Zoloft Label ), BIRTH CONTROL PILL (Trp) (View Birth Control Pill Review and Birth Control Pill Label ).

6002698-3 | Anoxic Encephalopathy, Cardio-respiratory Arrest, Fall
Adverse event was reported on Nov 20, 2008 by a Male patient taking Lortab (View Usage) (Dosage: 7.5 Mg, Po) was diagnosed with pain management, squamous cell carcinoma and. Location: UNITED STATES , 32 years of age, After Lortab was administered, patient had the following side effects: anoxic encephalopathy, cardio-respiratory arrest, fall (What is fall?). During the same period patient was treated with ERBITUX (250 Mg/m2, Once; Iv) (View Erbitux Review and Erbitux Label ), DURAGESIC 100 (100 Mcg Trd) (View Duragesic-100 Review and Duragesic-100 Label ), METHADONE HCL (Po) (View Methadone Hcl Review and Methadone Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

5947315-3 | Anoxic Encephalopathy, Cardio-respiratory Arrest, Fall
on Oct 20, 2008 Male patient from UNITED STATES , 32 years of age, weighting 181.2 lb, was diagnosed with analgesia, squamous cell carcinoma and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: anoxic encephalopathy, cardio-respiratory arrest, fall (What is fall?). Lortab dosage: 7.5mg Orally. During the same period patient was treated with ERBITUX (250 Mg/m2 Once, Iv) (View Erbitux Review and Erbitux Label ), DURAGESIC 100 (100 Mcg) (View Duragesic-100 Review and Duragesic-100 Label ), METHADONE HCL (Orally) (View Methadone Hcl Review and Methadone Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

5947314-1 | Anoxic Encephalopathy, Cardio-respiratory Arrest, Dyspnoea
on Oct 20, 2008 Male patient from UNITED STATES , 32 years of age, weighting 181.2 lb, was diagnosed with pain (What is pain?), squamous cell carcinoma and was treated with Lortab (View Usage). Patient had the following side effects: anoxic encephalopathy, cardio-respiratory arrest, dyspnoea. Lortab dosage: 7.5mg Orally. During the same period patient was treated with ERBITUX (250 Mg/m2 Once, Iv) (View Erbitux Review and Erbitux Label ), DURAGESIC 100 (100 Mcg) (View Duragesic-100 Review and Duragesic-100 Label ), METHADONE HCL (Orally) (View Methadone Hcl Review and Methadone Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

5943542-X | Amnesia, Confusional State, Disorientation, Impaired Driving Ability, Overdose, Road Traffic Accident, Somnambulism
Patient was taking Lortab (View Usage). After Lortab was administered, patient had the following side effects: amnesia, confusional state, disorientation, impaired driving ability, overdose, road traffic accident, somnambulism on Oct 28, 2008 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with insomnia and. Lortab dosage: . During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM (Unk) (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), AMBIEN (View Ambien Review and Ambien Label ).

5934521-7 | Anoxic Encephalopathy, Cardio-respiratory Arrest, Dyspnoea
Adverse event was reported on Oct 17, 2008 by a Male patient taking Lortab (View Usage) (Dosage: 7.5 Mg Po) was diagnosed with pain (What is pain?), squamous cell carcinoma and. Location: UNITED STATES , 32 years of age, weighting 181.2 lb, Patient experienced the following unwanted or unexpected effects: anoxic encephalopathy, cardio-respiratory arrest, dyspnoea. During the same period patient was treated with ERBITUX (250 Mg/m2 Once Iv) (View Erbitux Review and Erbitux Label ), DURAGESIC 100 (100 Mcg Trd) (View Duragesic-100 Review and Duragesic-100 Label ), METHADONE HCL (Po) (View Methadone Hcl Review and Methadone Hcl Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ).

5934483-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Calcium Decreased, Blood Glucose Increased, Blood Magnesium Decreased, Blood Triglycerides Increased, Cognitive Disorder, Confusional State, Overdose
on Oct 10, 2008 Male patient from UNITED STATES , 59 years of age, was diagnosed with pain (What is pain?), renal cell carcinoma and was treated with Lortab (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood calcium decreased, blood glucose increased, blood magnesium decreased, blood triglycerides increased, cognitive disorder, confusional state, overdose. Lortab dosage: 10 Mg Prn Po. During the same period patient was treated with NEVAXAR (400 Mg 2/d Po) (View Nevaxar Review and Nevaxar Label ), REMERON (View Remeron Review and Remeron Label ), TAGAMET (View Tagamet Review and Tagamet Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

5930434-5 | Aggression, Headache
on Oct 06, 2008 Female patient from UNITED STATES , 17 years of age, weighting 149.9 lb, was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: aggression, headache (What is headache?). Lortab dosage: 10 Mg Twice Po. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ).

5897315-7 | Dental Caries
Patient was taking Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: dental caries on May 15, 2008 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with pain (What is pain?) and. Lortab dosage: . During the same period patient was treated with ACTIQ (See Image) (View Actiq Review and Actiq Label ), DURAGESIC 100 (50 Ug, Q 1hr, Transdermal ; 75 Ug, Q 1hr, Transdermal ; 100 Ug, Q 1hr, Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), DURAGESIC 100 (50 Ug, Q 1hr, Transdermal ; 75 Ug, Q 1hr, Transdermal ; 100 Ug, Q 1hr, Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), DURAGESIC 100 (50 Ug, Q 1hr, Transdermal ; 75 Ug, Q 1hr, Transdermal ; 100 Ug, Q 1hr, Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5897314-5 | Mental Status Changes
Adverse event was reported on Sep 26, 2007 by a Female patient taking Lortab (View Usage) (Dosage: ) was diagnosed with acute coronary syndrome and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: mental status changes. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), CHANTIX (View Chantix Review and Chantix Label ), RIVAROXABAN() (View Rivaroxaban() Review and Rivaroxaban() Label ), ASA(ACETYLSALCYLIC ACID) 81MG (Low Dose) (View Asa(acetylsalcylic Acid) 81mg Review and Asa(acetylsalcylic Acid) 81mg Label ), PLAVIX (View Plavix Review and Plavix Label ), FOLTX /01502401/ (CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE) (View Foltx /01502401/ (cyanocobalamin, Folic Acid, Pyridoxine) Review and Foltx /01502401/ (cyanocobalamin, Folic Acid, Pyridoxine) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

5883717-1 | Coordination Abnormal, Disorientation, Dysuria, Feeling Drunk, Gait Disturbance, Incontinence, Nerve Injury, Oedema Peripheral
on Aug 28, 2008 Female patient from UNITED STATES , 53 years of age, was diagnosed with neuralgia and was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: coordination abnormal, disorientation, dysuria, feeling drunk, gait disturbance, incontinence, nerve injury, oedema peripheral. Lortab dosage: . During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LYRICA (View Lyrica Review and Lyrica Label ), POTASSIUM CHLORIDE (40 Mg/d Po) (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (40 Mg/ D Po) (View Furosemide Review and Furosemide Label ), DARVOCET (View Darvocet Review and Darvocet Label ).

5850380-5 | Alanine Aminotransferase Increased, Blood Bilirubin Increased, Incorrect Dose Administered, Therapeutic Agent Toxicity
on Aug 01, 2008 Male patient from UNITED STATES , 25 years of age, was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood bilirubin increased, incorrect dose administered, therapeutic agent toxicity. Lortab dosage: .

5825578-2 | Ileus, Urinary Retention
Patient was taking Lortab (View Usage). Patient had the following side effects: ileus, urinary retention on May 02, 2008 from UNITED STATES Additional patient health information: Female patient , 36 years of age, weighting 162.0 lb, was diagnosed with procedural pain and. Lortab dosage: Every 4-6hrs Orally. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CHANTIX (View Chantix Review and Chantix Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PEPCID (View Pepcid Review and Pepcid Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), PROPOFOL (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

5818864-3 | Anoxic Encephalopathy, Cardiac Arrest, Dyspnoea, Fall
Adverse event was reported on Jul 02, 2008 by a Male patient taking Lortab (View Usage) (Dosage: 250 Mg/m2 Once Iv) was diagnosed with pain (What is pain?), squamous cell carcinoma and. Location: UNITED STATES , 32 years of age, After Lortab was administered, patient had the following side effects: anoxic encephalopathy, cardiac arrest (What is cardiac arrest?), dyspnoea, fall (What is fall?). During the same period patient was treated with ERBITUX (250 Mg/m2 Once Iv) (View Erbitux Review and Erbitux Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

5814185-3 | Dysuria, Ileus, Nausea, Residual Urine, Retching, Urinary Retention
on May 02, 2008 Female patient from UNITED STATES , 36 years of age, weighting 162.0 lb, was diagnosed with procedural pain and was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria, ileus, nausea (What is nausea?), residual urine, retching, urinary retention. Lortab dosage: Every 4-6hrs Orally. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CHANTIX (View Chantix Review and Chantix Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PEPCID (View Pepcid Review and Pepcid Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

5798435-8 | Incorrect Dose Administered
on Jul 01, 2008 Male patient from UNITED STATES , 53 years of age, was treated with Lortab (View Usage). Patient had the following side effects: incorrect dose administered. Lortab dosage: Tablet.

5797450-8 | Abscess, Arthritis Bacterial, Blood Culture Positive, Chills, Gait Disturbance, Hyperhidrosis, Joint Effusion, Joint Range Of Motion Decreased, Muscle Disorder
Patient was taking Lortab (View Usage). After Lortab was administered, patient had the following side effects: abscess (What is abscess?), arthritis bacterial, blood culture positive, chills, gait disturbance, hyperhidrosis, joint effusion, joint range of motion decreased, muscle disorder (What is muscle disorder?) on Jun 16, 2008 from UNITED STATES Additional patient health information: Male patient , 23 years of age, was diagnosed with pain (What is pain?) and. Lortab dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5782915-5 | Malaise, Nausea
Adverse event was reported on Jun 19, 2008 by a Male patient taking Lortab (View Usage) (Dosage: 10mg One Po Q6hrs/prn (duration: Lifetime)) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: malaise, nausea (What is nausea?).

5754919-X | Ileus, Urinary Retention
on May 02, 2008 Female patient from UNITED STATES , 36 years of age, weighting 162.0 lb, was diagnosed with procedural pain and was treated with Lortab (View Usage). Patient had the following side effects: ileus, urinary retention. Lortab dosage: Every 4-6hrs Orally. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CHANTIX (View Chantix Review and Chantix Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PEPCID (View Pepcid Review and Pepcid Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), PROPOFOL (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

5751851-2 | Dental Caries, Dependence, Overdose, Tooth Loss
on May 15, 2008 Female patient from UNITED STATES , 40 years of age, was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: dental caries, dependence, overdose, tooth loss. Lortab dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

5741205-7 | Abdominal Pain, Asthenia, Constipation
Patient was taking Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, constipation (What is constipation?) on Apr 28, 2008 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 167.3 lb, . Lortab dosage: 10 Mg Prn Po. During the same period patient was treated with HYDROMORPHONE HCL (4 Mg Prn Po) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), TAXOL (504 Mcg 1/w Iv) (View Taxol Review and Taxol Label ), BEVACIZUMAB (10 Mg/kg 1/2w Iv) (View Bevacizumab Review and Bevacizumab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ). Patient was hospitalized.

5725832-9 | Constipation, Dental Caries, Depression, Multiple Sclerosis, Post Laminectomy Syndrome, Suicidal Ideation, Tooth Loss, Vision Blurred
Adverse event was reported on Apr 14, 2008 by a Male patient taking Lortab (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?), pain in extremity and. Location: UNITED STATES , 43 years of age, weighting 270.1 lb, Patient had the following side effects: constipation (What is constipation?), dental caries, depression (What is depression?), multiple sclerosis (What is multiple sclerosis?), post laminectomy syndrome, suicidal ideation, tooth loss, vision blurred. During the same period patient was treated with ACTIQ (1600 Mcg Prn Buc) (View Actiq Review and Actiq Label ).

5725830-5 | Abdominal Pain, Asthenia, Constipation
on Apr 11, 2008 Female patient from UNITED STATES , 66 years of age, weighting 167.3 lb, was treated with Lortab (View Usage). After Lortab was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, constipation (What is constipation?). Lortab dosage: Po. During the same period patient was treated with HYDROMORPHONE HCL (Po) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), TAXOL (504 Mcg 1/w Iv) (View Taxol Review and Taxol Label ), BEVACIZUMAB (10 Mg/kg 1 2/w Iv) (View Bevacizumab Review and Bevacizumab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5684351-9 | Dependence
on Jan 24, 2008 Male patient from UNITED STATES , 47 years of age, was treated with Lortab (View Usage). Patient experienced the following unwanted or unexpected effects: dependence. Lortab dosage: .

5638070-5 | Road Traffic Accident, Somnambulism
Patient was taking Lortab (View Usage). Patient had the following side effects: road traffic accident, somnambulism on Feb 13, 2008 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with insomnia and. Lortab dosage: . During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM (Unk) (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), AMBIEN (View Ambien Review and Ambien Label ).